Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2021-07-07 Regulatory Filings
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 90% confidence The document text is extremely short (133 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report title, no regulatory references, and no indication of any report or announcement. Given the lack of content, the document cannot be classified as a report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2021-07-07 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated 5th July 2021 from Wockhardt Limited announcing a visit by HRH The Prince of Wales to their UK manufacturing facility. It contains no financial data, regulatory filings, or detailed report content. It is a corporate announcement intended for public and investor relations purposes. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification. The content is a standalone press release about a corporate event, which aligns best with a general Regulatory Filings (RNS) category as a miscellaneous announcement that does not fit other specific categories.
2021-07-05 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the incorporation of a new subsidiary company, Wockhardt Biologics Limited. It references compliance with SEBI Listing Regulations and provides details about the subsidiary's capital structure and shareholding. There is no financial data, report, or detailed analysis present. The document is an announcement of a corporate action (incorporation of a subsidiary) rather than a financial report or management discussion. This fits best under the category of Capital/Financing Update (CAP), as it relates to changes in the company's capital structure through the creation of a new subsidiary and shareholding details.
2021-07-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window due to upcoming financial results for the quarter ended 30th June 2021. It informs designated persons not to trade during this period and mentions that the date of the board meeting for approval of financial results will be intimated later. The document is short (1323 characters) and serves as an announcement related to trading restrictions ahead of financial results, not the financial results report itself. Therefore, it is neither an Interim/Quarterly Report nor an Earnings Release. It is also not a certification or a regulatory compliance filing. The best fitting category is a Regulatory Filing (RNS) as it is a general regulatory announcement related to trading restrictions and compliance with the company's code of conduct.
2021-06-30 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 31(1) and 31(3) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. It pertains to the creation of pledge (encumbrance) on equity shares by promoters of Wockhardt Limited. The content includes detailed shareholding and encumbrance information, dates of creation of pledge, and percentage of shares pledged. This type of disclosure is related to changes in significant share ownership or encumbrance and is typically classified as a Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes.
2021-06-23 English
Related Party Transactions
Regulatory Filings
2021-06-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.